GSTM1 and atherosclerosis: The diverse Hb/heme-triggered disease processes (i.e., NO consumption, lipid peroxidative processes) are therefore likely to modulate pathologies of the cardiovascular system such as atherosclerosis or typical vascular complications of hemolytic anemias.